Cargando…

Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors

BACKGROUND: The grading of pancreatic neuroendocrine neoplasms (PanNENs) is associated with the choice of treatment strategy. The aim of this study is to identify the magnetic resonance imaging (MRI) features in differentiating pancreatic neuroendocrine tumors (PanNETs) grade 1/2 (G1/G2) and pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Chuangen, Chen, Xiao, Xiao, Wenbo, Wang, Qidong, Sun, Ke, Wang, Zhongqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349505/ https://www.ncbi.nlm.nih.gov/pubmed/28331340 http://dx.doi.org/10.2147/OTT.S127803

Ejemplares similares

Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors
por: Guo, Chuangen, et al.
Publicado: (2017)

Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging
por: Guo, Chuangen, et al.
Publicado: (2017)

The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis
por: Guo, Chuangen, et al.
Publicado: (2018)

Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage
por: De Robertis, Riccardo, et al.
Publicado: (2017)

CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms
por: Chen, Xin, et al.
Publicado: (2020)

Pancreatic neuroendocrine tumor: prediction of the tumor grade using magnetic resonance imaging findings and texture analysis with 3-T magnetic resonance
por: Guo, Chuan-gen, et al.
Publicado: (2019)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

Bone Loss in Patients with Pancreatic Neuroendocrine Tumors
por: Tong, He, et al.
Publicado: (2022)

Microscopic Invasion of Nerve Is Associated With Aggressive Behaviors in Pancreatic Neuroendocrine Tumors
por: Zhou, Hao, et al.
Publicado: (2021)

The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms
por: Quan, Li, et al.
Publicado: (2022)

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms
por: Leoncini, Emanuele, et al.
Publicado: (2017)

Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study
por: Kim, Haeryoung, et al.
Publicado: (2020)

Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology
por: Han, Xu, et al.
Publicado: (2018)

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms
por: Zhang, Qi, et al.
Publicado: (2021)

Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms
por: Xu, Wenbin, et al.
Publicado: (2021)

Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
por: Que, Qing-Yang, et al.
Publicado: (2022)

The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
por: Venizelos, Andreas, et al.
Publicado: (2021)

Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging
por: Zhang, Huifeng, et al.
Publicado: (2023)

Imaging of Pancreatic Neuroendocrine Neoplasms
por: Chiti, Giuditta, et al.
Publicado: (2021)

Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors
por: Marchese, Ugo, et al.
Publicado: (2022)

Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
por: Al-Toubah, T., et al.
Publicado: (2021)

Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
por: Chen, Jingci, et al.
Publicado: (2021)

Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI
por: Zhao, Weiwei, et al.
Publicado: (2018)

Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021)

Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience
por: Douangprachanh, Sathathone, et al.
Publicado: (2022)

Current update on imaging for pancreatic neuroendocrine neoplasms
por: Segaran, Nicole, et al.
Publicado: (2021)

Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Low Grade Neuroendocrine Tumors of the Lung
por: Melosky, Barbara
Publicado: (2017)

World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution
por: Yang, Min, et al.
Publicado: (2020)

The added value of intravoxel incoherent motion diffusion weighted imaging parameters in differentiating high-grade pancreatic neuroendocrine neoplasms from pancreatic ductal adenocarcinoma
por: Ma, Wanling, et al.
Publicado: (2019)

The Diagnostic and Grading Accuracy of (68)Ga-DOTATATE and (18)F-FDG PET/MR for Pancreatic Neuroendocrine Neoplasms
por: Zhou, Jinxin, et al.
Publicado: (2022)

Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system
por: Zhang, Rihong, et al.
Publicado: (2022)

Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences
por: Qin, Jiang-bo, et al.
Publicado: (2017)

Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals
por: Wang, Zhi-Jie, et al.
Publicado: (2019)

Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms
por: Eads, Jennifer R, et al.
Publicado: (2023)

The Predicting Role of the Neutrophil-to-Lymphocyte Ratio for the Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumors
por: Oh, Dongwook, et al.
Publicado: (2022)

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nc2dq2iqk63hcpegg0m5c01av5